SKYE
COM:SKYEBIOSCIENCE
Skye Bioscience
- Stock
Last Close
4.17
22/11 21:00
Market Cap
81.91M
Beta: -
Volume Today
119.78K
Avg: -
Preview
Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page
Dec '13 | Dec '14 | Dec '15 | Dec '16 | Dec '17 | Dec '18 | Dec '19 | Dec '20 | Dec '21 | Dec '22 | Dec '23 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
net income | -120.40K - | -2.73M 2,170.85% | -4.84M 77.06% | -3.18M 34.35% | -3.09M 2.64% | -19.19M 520.31% | 1.05M 105.48% | -6.56M 723.74% | -8.52M 29.90% | -19.48M 128.60% | -37.64M 93.23% | |
depreciation and amortization | 10.87K - | 1.91K 82.45% | 9.95K 421.65% | 14.92K 49.86% | 8.04K 46.10% | 1.54K 80.79% | 1.46K 5.31% | 1.87K 28.04% | 34.13K 1,723.24% | 115.00K 236.93% | 124.25K 8.05% | |
deferred income tax | 103.50K - | -1.24M 1,293.43% | -614.56K 50.25% | 14.27M 2,421.83% | -8.69M 160.88% | -436.27K 94.98% | -96.79K 77.81% | |||||
stock based compensation | 10.77K - | 414.34K 3,746.84% | 706.37K 70.48% | 608.68K 13.83% | 674.96K 10.89% | 680.46K 0.81% | 302.74K 55.51% | 869.21K 187.11% | 629.03K 27.63% | 987.51K 56.99% | ||
change in working capital | 120.40K - | 500.08K 315.34% | -418.57K 183.70% | 40.52K 109.68% | -290.77K 817.66% | 100.19K 134.46% | 295.71K 195.15% | 94.19K 68.15% | 646.94K 586.84% | -761.90K 217.77% | -469.31K 38.40% | |
accounts receivables | -18.43K - | |||||||||||
inventory | 132.92K - | |||||||||||
accounts payables | 10.75K - | 407.34K 3,687.84% | -274.14K 167.30% | 149.29K 154.46% | -173.73K 216.37% | -85.32K 50.89% | 134.21K 257.30% | 241.56K 79.99% | 518.64K 114.70% | 799.74K 54.20% | -701.28K 187.69% | |
other working capital | -4.84K - | 92.73K 2,017.20% | -144.43K 255.74% | -108.78K 24.68% | -117.05K 7.60% | 185.52K 258.50% | 161.50K 12.94% | -147.37K 191.25% | 128.31K 187.06% | -1.56M 1,317.13% | 231.98K 114.85% | |
other non cash items | -25.37K - | 466.20K 1,937.82% | 1.00M 115.35% | 98.56K 90.18% | 84.70K 14.06% | 205.52K 142.64% | 629.29K 206.19% | 544.03K 13.55% | 593.80K 9.15% | 6.76M 1,037.65% | 24.99M 269.89% | |
net cash provided by operating activities | -14.49K - | -1.76M 12,009.06% | -3.73M 112.40% | -3.55M 4.70% | -3.30M 7.17% | -3.94M 19.55% | -6.03M 52.88% | -6.05M 0.43% | -6.47M 6.95% | -12.74M 96.82% | -13.95M 9.48% | |
investments in property plant and equipment | -49.12K - | -23.26K 52.64% | -1.98K 91.48% | -11.12K 460.90% | -19.65K 76.79% | -4.38K 77.69% | -7.23K - | -90.87K 1,156.79% | -28.06K 69.12% | -12.55K 55.27% | ||
acquisitions net | 5.31M - | 1.08M 79.72% | ||||||||||
purchases of investments | ||||||||||||
sales maturities of investments | 5.53M - | |||||||||||
other investing activites | 11K - | -66.46K - | 1.08M 1,720.18% | |||||||||
net cash used for investing activites | -38.12K - | -23.26K 38.97% | -1.98K 91.48% | -11.12K 460.90% | -19.65K 76.79% | -4.38K 77.69% | -7.23K - | -90.87K 1,156.79% | 5.21M 5,838.55% | 6.60M 26.50% | ||
debt repayment | -17.26K - | -3.99M - | -566.70K 85.78% | -891.66K - | -4.71M 428.71% | |||||||
common stock issued | 48.60K - | 1.99M 3,986.01% | 721.02K 63.69% | 50K 93.07% | 187.55K 275.10% | 9.79K 94.78% | 1.92M 19,497.43% | 6.09M 217.06% | 6.06M 0.37% | 1.97K 99.97% | 11.73M 596,491.10% | |
common stock repurchased | ||||||||||||
dividends paid | ||||||||||||
other financing activites | 47.05K - | 6.02M - | 357.67K 94.06% | 3.33M 829.76% | 5.53M 66.33% | 8.07M 45.91% | 1.18M 85.36% | 7.02M 493.65% | 680.90K 90.30% | 16.70M 2,353.02% | ||
net cash used provided by financing activities | 78.39K - | 1.99M 2,433.13% | 6.74M 239.60% | 407.67K 93.95% | 3.51M 761.73% | 5.54M 57.73% | 6.00M 8.37% | 6.70M 11.60% | 13.08M 95.19% | -208.79K 101.60% | 16.44M 7,975.36% | |
effect of forex changes on cash | ||||||||||||
net change in cash | 25.78K - | 207.33K 704.17% | 3.01M 1,353.66% | -3.16M 204.73% | 195.13K 106.18% | 1.59M 716.62% | -23.37K 101.47% | 639.46K 2,836.25% | 6.51M 918.61% | -7.74M 218.80% | 9.09M 217.43% | |
cash at beginning of period | 26.40K - | 207.33K - | 3.22M 1,453.66% | 64.82K 97.99% | 264.38K 307.87% | 1.86M 602.72% | 1.83M 1.26% | 2.47M 34.86% | 8.99M 263.28% | 1.25M 86.10% | ||
cash at end of period | 52.19K - | 207.33K 297.29% | 3.22M 1,453.66% | 64.82K 97.99% | 259.95K 301.04% | 1.86M 614.69% | 1.83M 1.26% | 2.47M 34.86% | 8.99M 263.28% | 1.25M 86.10% | 10.34M 727.52% | |
operating cash flow | -14.49K - | -1.76M 12,009.06% | -3.73M 112.40% | -3.55M 4.70% | -3.30M 7.17% | -3.94M 19.55% | -6.03M 52.88% | -6.05M 0.43% | -6.47M 6.95% | -12.74M 96.82% | -13.95M 9.48% | |
capital expenditure | -49.12K - | -23.26K 52.64% | -1.98K 91.48% | -11.12K 460.90% | -19.65K 76.79% | -4.38K 77.69% | -7.23K - | -90.87K 1,156.79% | -28.06K 69.12% | -12.55K 55.27% | ||
free cash flow | -63.61K - | -1.78M 2,695.85% | -3.73M 109.73% | -3.56M 4.45% | -3.32M 6.91% | -3.95M 18.97% | -6.03M 52.71% | -6.06M 0.55% | -6.57M 8.32% | -12.77M 94.53% | -13.96M 9.34% |
All numbers in USD (except ratios and percentages)